Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Mar 2013

Manu Peter, Correll Christoph U, Wampers Martien, van Winkel Ruud, Yu Weiping, Mitchell Alex J, De Hert Marc

Abstract excerpt

BACKGROUND: In 2010, the American Diabetes Association recommended that individuals with hemoglobin A1c 5.7-6.4% be classified as prediabetic even in the absence of impaired fasting glucose (IFG). AIM OF STUDY: To compare the clinical and metabolic characteristics of patients receiving antipsychotic drugs who have normal glucose tolerance (NGT), hemoglobin A1c 5.7-6.4% or IFG (fasting glucose 100-125 mg/dL)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glucose Intolerance
Share to Glucose Tolerance Test

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycated Hemoglobin

Share to Mood Disorders

Share to Personality Disorders

Share to Prediabetic State

Share to Psychotic Disorders

Share to Waist Circumference

Source

Identifiers

PMID: 22652493
DOI: 10.1016/j.euroneuro.2012.05.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs.PMID 22652493Read ↗

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.Semantic proximity Read ↗

Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.Semantic proximity Read ↗

Quality of Diabetes Care in Patients with Schizophrenia: A Case-Control Study.Semantic proximity Read ↗

Haemoglobin variants may cause significant differences in haemoglobin A1c as measured by high-performance liquid chromatography and enzymatic methods in diabetic patients: a cross-sectional study.Semantic proximity Read ↗

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.Semantic proximity Read ↗

Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and DiscontinuationSemantic proximity Read ↗

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.Semantic proximity Read ↗

Clinical assessment of liraglutide use in prediabetic and obese schizophrenic patients: A systematic literature review and meta-analysisSemantic proximity Read ↗

Factors in antipsychotic drug selection: tolerability considerations.Semantic proximity Read ↗

[Olanzapine-induced diabetes mellitus].Semantic proximity Read ↗

Subjects with impaired fasting glucose: evolution in a period of 6 years.Semantic proximity Read ↗

Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.